DKK1 and non-small cell lung carcinoma: Our study therefore emphasize that further studies should be performed with respect to DKK1 and its interactome to reveal how it can be used to sensitize NSCLC to platinum-based therapy, especially in an in vivo setting such as NSCLC patient-derived xenografts.